GOCO - GoHealth Inc Stock Price, Fair Value and News

9.85USD-0.65 (-6.19%)Delayed as of 08 May 2024, 02:45 pm ET

Market Summary

USD9.85-0.65

Delayedas of 08 May 2024, 02:45 pm

-6.19%

GOCO Stock Price

View Fullscreen

GOCO RSI Chart

GOCO Valuation

Market Cap

97.6M

Price/Earnings (Trailing)

-1.54

Price/Sales (Trailing)

0.13

EV/EBITDA

-6.14

Price/Free Cashflow

0.89

GOCO Price/Sales (Trailing)

GOCO Profitability

Operating Margin

78.36%

EBT Margin

-20.57%

Return on Equity

-27.38%

Return on Assets

-4.22%

Free Cashflow Yield

111.86%

GOCO Fundamentals

GOCO Revenue

Revenue (TTM)

734.7M

Rev. Growth (Yr)

298.84%

Rev. Growth (Qtr)

109.56%

GOCO Earnings

Earnings (TTM)

-63.3M

Earnings Growth (Yr)

98%

Earnings Growth (Qtr)

94.87%

Breaking Down GOCO Revenue

52 Week Range

9.8522.85

(Low)(High)

Last 7 days

3.7%

Last 30 days

-0.8%

Last 90 days

-14.3%

Trailing 12 Months

-18.9%

How does GOCO drawdown profile look like?

GOCO Financial Health

Current Ratio

1.29

Debt/Equity

1.83

Debt/Cashflow

0.26

GOCO Investor Care

Shares Dilution (1Y)

10.03%

Diluted EPS (TTM)

-7.17

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2023	544.2M	528.4M	527.4M	734.7M
2022	1.1B	1.1B	1.0B	631.7M
2021	940.5M	1.0B	1.1B	1.1B
2020	568.7M	654.3M	739.9M	877.4M
2019	0	0	311.8M	483.1M
2018	0	0	0	226.2M

Get all data in R, Python etc through our Historical Stock Data APIs

Tracking the Latest Insider Buys and Sells of GoHealth Inc

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
May 05, 2024	burd brad	sold (taxes)	-8,229	10.11	-814	chief legal officer
Apr 10, 2024	schulz jason	sold (taxes)	-30,192	9.6	-3,145	chief financial officer
Apr 10, 2024	kotte vijay	sold (taxes)	-156,269	9.6	-16,278	chief executive officer
Apr 01, 2024	schulz jason	acquired	-	-	33,333	chief financial officer
Apr 01, 2024	kotte vijay	acquired	-	-	166,666	chief executive officer
Apr 01, 2024	burd brad	acquired	-	-	50,000	chief legal officer
Apr 01, 2024	hargis mike	acquired	-	-	100,000	chief operating officer
Mar 21, 2024	hargis mike	sold (taxes)	-66,537	10.34	-6,435	chief operating officer
Mar 21, 2024	burd brad	sold (taxes)	-11,363	10.34	-1,099	chief legal officer
Feb 11, 2024	burd brad	sold (taxes)	-1,688	12.99	-130	chief legal officer

Which funds bought or sold GOCO recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
May 06, 2024	Empowered Funds, LLC	added	7.72	-36,611	205,323	-%
May 02, 2024	Quent Capital, LLC	unchanged	-	-1,070	3,973	-%
May 01, 2024	CONCOURSE FINANCIAL GROUP SECURITIES, INC.	sold off	-	-	-	-%
Apr 30, 2024	North Star Investment Management Corp.	added	43.5	817	7,073	-%
Apr 30, 2024	Avior Wealth Management, LLC	new	-	10.00	10.00	-%
Apr 25, 2024	Bank of New York Mellon Corp	reduced	-6.44	-41,914	117,500	-%
Apr 23, 2024	AMALGAMATED BANK	reduced	-61.22	-4,000	1,000	-%
Apr 23, 2024	Global Retirement Partners, LLC	unchanged	-	-131	673	-%
Apr 05, 2024	CWM, LLC	unchanged	-	-	-	-%
Mar 11, 2024	VANGUARD GROUP INC	added	1.33	-192,747	2,680,270	-%

Are Funds Buying or Selling GOCO?

Are funds buying GOCO calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own GOCO

No. of Funds

Unveiling GoHealth Inc's Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Aug 25, 2023	nvx holdings, inc.	39.6%	6,232,352	SC 13D/A
Aug 25, 2023	centerbridge associates iii, l.p.	64.2%	9,566,028	SC 13D/A
May 19, 2023	nvx holdings, inc.	40.8%	6,232,352	SC 13D/A
May 19, 2023	centerbridge associates iii, l.p.	66.3%	9,566,028	SC 13D/A
Feb 14, 2023	harris associates l p	0.0%	0	SC 13G/A
Feb 09, 2023	vanguard group inc	1.98%	176,102	SC 13G/A
Dec 12, 2022	ccp iii cayman gp ltd.	66.3%	9,459,897	SC 13D/A
Dec 02, 2022	ccp iii cayman gp ltd.	64.5%	9,213,506	SC 13D/A
Nov 25, 2022	nvx holdings, inc.	42.2%	6,232,352	SC 13D
Nov 25, 2022	ccp iii cayman gp ltd.	62.3%	8,897,947	SC 13D

Recent SEC filings of GoHealth Inc

View All Filings

Date Filed	Form Type	Document
May 07, 2024	4	Insider Trading
Apr 26, 2024	DEF 14A	DEF 14A
Apr 26, 2024	DEFA14A	DEFA14A
Apr 12, 2024	4	Insider Trading
Apr 12, 2024	4	Insider Trading
Apr 03, 2024	4	Insider Trading
Apr 03, 2024	4	Insider Trading
Apr 03, 2024	4	Insider Trading
Apr 03, 2024	4	Insider Trading
Mar 22, 2024	4	Insider Trading

Peers (Alternatives to GoHealth Inc)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
ARGO	1.0T	1.3B	1.04%	3195.96%	-4.9K	773.83	-10.27%	-34.69%
AJG	53.6B	10.6B	0.45%	13.83%	49.04	5.04	20.42%	-6.05%
AIG	53.3B	48.4B	3.31%	49.36%	11.03	1.1	-4.15%	-20.63%
TRV	49.7B	42.9B	-6.01%	18.86%	15.83	1.16	13.52%	12.15%
AFL	48.1B	19.3B	-0.90%	25.15%	8.99	2.49	3.03%	17.35%
ACGL	36.7B	13.6B	3.49%	28.99%	8.27	2.7	41.83%	201.02%
AFG	10.8B	8.0B	-2.57%	11.52%	12.28	1.36	11.14%	7.56%
MID-CAP
UNM	9.9B	12.6B	-2.35%	17.17%	7.52	0.79	4.24%	-13.40%
AIZ	9.3B	11.1B	-0.68%	35.68%	14.45	0.83	9.21%	132.28%
LNC	5.0B	11.9B	-5.21%	37.41%	3.67	0.41	-33.27%	234.43%
AEL	4.5B	2.8B	-0.20%	45.14%	21.34	1.58	100.59%	-89.04%
SMALL-CAP
BRP	1.7B	1.3B	0.25%	17.87%	-31.85	1.37	18.74%	30.90%
AMSF	911.0M	308.9M	0.21%	-15.21%	14.77	2.95	3.79%	10.94%
AMBC	815.9M	314.0M	13.99%	19.72%	14.19	2.6	-29.20%	-88.19%
AAME	35.9M	186.8M	-18.72%	-19.82%	-209.99	0.19	-0.56%	-111.21%

GoHealth Inc News

Latest updates

GoHealth Inc Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

Income Statement (Quarterly)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q3	2018Q4
Revenue	109.6%	276,697,000	132,037,000	142,779,000	183,158,000	69,376,000	133,052,000	158,654,000	270,593,000	449,600,000	211,734,000	196,902,000	204,179,000	445,923,000	163,360,000	127,057,000	141,010,000	308,491,000	197,950,500	87,410,000	-
Cost Of Revenue	14.2%	41,085,000	35,992,000	36,422,000	45,462,000	20,629,000	48,044,000	51,074,000	67,923,000	99,886,000	53,632,000	37,442,000	48,375,000	94,682,000	25,827,000	36,559,000	42,134,000	90,384,000	-	25,055,000	-
Costs and Expenses	53.9%	261,637,000	170,013,000	195,795,000	188,907,000	202,554,000	192,191,000	259,695,000	295,901,000	872,754,000	260,440,000	215,899,000	202,769,000	304,092,000	361,156,000	141,465,000	135,183,000	284,393,000	-	164,730,000	-
S&GA Expenses	51.4%	19,629,000	12,967,000	37,855,000	22,618,000	24,633,500	25,611,000	38,106,000	29,217,000	28,906,000	24,295,000	25,297,000	19,685,000	19,828,500	156,551,000	10,359,000	10,491,000	13,674,000	-	65,123,000	-
EBITDA Margin	77.1%	-0.10	-0.42	-0.45	-0.52	-0.48	-0.58	-0.53	-0.45	-0.46	0.07	-0.08	-0.07	-0.07	-0.24	0.05	0.06	0.07	0.09	0.11	0.15
Interest Expenses	1.1%	17,751,000	17,565,000	17,265,000	16,891,000	17,317,000	15,630,000	12,724,000	11,398,000	9,619,000	6,921,000	8,277,000	8,688,000	8,591,000	8,636,000	8,986,000	6,756,000	8,076,000	-	31,000	-
Income Taxes	450.9%	379,000	-108,000	-73,000	-44,000	292,000	-	-	472,000	118,000	-79,000	-32,000	-31,000	5,000	62,000	-22,000	-2,000	44,000	-	-78,000	-
Earnings Before Taxes	96.6%	-1,915,000	-56,312,000	-70,302,000	-22,587,000	-150,445,000	-74,654,000	-113,752,000	-36,769,000	-432,077,000	-55,597,000	-39,253,000	-7,291,000	133,104,500	-206,434,000	-22,889,000	-939,000	16,039,000	-	-77,418,000	-
EBT Margin	63.8%	-0.21	-0.57	-0.60	-0.66	-0.59	-0.65	-0.59	-0.50	-0.50	0.03	-0.12	-0.11	-0.11	-0.29	0.04	0.05	0.06	0.07	0.09	0.12
Net Income	94.9%	-1,226,000	-23,910,000	-28,942,000	-9,179,000	-61,399,000	-30,005,000	-43,819,000	-13,483,000	-155,026,000	-20,240,000	-12,004,000	-2,087,000	35,956,500	-56,420,000	-22,867,000	-937,000	15,995,000	-	-77,340,000	-
Net Income Margin	63.2%	-0.09	-0.23	-0.25	-0.27	-0.24	-0.24	-0.21	-0.18	-0.18	0.00	-0.03	-0.05	-0.05	-0.09	-0.15	-0.17	-0.20	0.07	0.09	0.12
Free Cashflow	996.9%	71,301,000	6,500,000	10,861,000	20,479,000	-40,999,000	95,526,000	-48,109,000	54,486,000	-226,587,000	-40,169,000	-63,452,000	31,202,000	-143,052,000	33,004,000	-27,756,000	23,587,000	-9,284,000	-3,698,000	-3,698,000	-

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet															(In Millions)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2019Q4
Assets	4.3%	1,500	1,437	1,482	1,543	1,659	2,002	1,898	1,963	2,069	2,131	2,112	2,098	2,109	1,938	1,602
Current Assets	37.6%	476	346	368	375	415	468	333	392	429	257	296	321	392	417	144
Cash Equivalents	244.1%	91.00	26.00	25.00	32.00	16.00	215	76.00	130	84.00	85.00	113	174	144	295	12.00
Net PPE	-	-	-	-	-	-	-	-	-	-	27.00	24.00	21.00	17.00	15.00	6.00
Goodwill	-	-	-	-	-	-	-	-	-	-	387	387	387	387	387	387
Current Liabilities	69.9%	370	218	210	210	265	255	142	141	217	133	114	100	127	145	113
Long Term Debt	-14.9%	423	497	496	490	505	660	662	663	665	439	415	396	396	397	288
LT Debt, Current	-	75.00	-	-	19.00	5.00	5.00	5.00	5.00	5.00	4.00	4.00	4.00	4.00	4.00	3.00
LT Debt, Non Current	-14.9%	423	497	496	490	505	660	662	663	665	439	415	396	396	397	288
Shareholder's Equity	1.4%	231	228	461	523	269	689	758	860	892	1,317	1,365	1,396	1,399	1,263	860
Retained Earnings	-0.3%	-420	-419	-395	-366	-357	-295	-265	-221	-208	-53.06	-32.88	-20.89	-18.80	-54.76	-
Additional Paid-In Capital	0.7%	654	649	646	630	626	621	613	583	561	550	504	466	399	392	-
Shares Outstanding	-2.1%	9.00	9.00	9.00	9.00	8.00	8.00	8.00	8.00	7.00	8.00	6.00	6.00	6.00	6.00	-
Minority Interest	-1.2%	175	177	211	260	274	364	412	499	539	820	895	952	1,019	925	-
Float	-	-	-	88.00	-	-	-	49.00	-	-	-	725	-	-	-	-

Cashflow (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Cashflow (Quarterly)																					(In Thousands)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q3	2019Q2	2018Q4
Cashflow From Operations	996.9%	71,301	6,500	10,861	20,479	-40,999	95,526	-48,109	54,486	-226,587	-40,169	-63,452	31,202	-143,052	33,004	-27,756	23,587	-9,284	-	-3,698	-	-
Share Based Compensation	95.6%	4,251	2,173	8,681	4,444	4,366	5,483	12,138	5,155	7,197	7,389	7,599	5,112	3,083	212,070	597	479	448	-	-	-	-
Cashflow From Investing	-64.7%	-5,645	-3,427	-2,434	-2,226	-1,416	-2,438	-3,661	-5,997	-532	-11,360	-4,169	-3,740	-2,500	-4,259	-4,242	-3,522	-810,010	-	-814	-	-
Cashflow From Financing	50.4%	-1,087	-2,193	-15,429	-2,397	-156,591	46,003	-1,358	-3,105	226,346	23,855	6,612	2,276	-4,915	147,678	-2,267	120,167	830,879	-	1,407	-	-

Get Full Access to Grufity – and Unlimited Downloads

Gain full access to fair value, watchlists, stock screener, unlimited page visits, and additional features by joining as a member today for just $1.99.

Try For Just $1.99

GOCO Income Statement

2023-12-31

Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Income Statement [Abstract]
Net revenues	$ 734,671	$ 631,675	$ 1,062,415
Operating expenses:
Revenue share	158,961	187,670	239,335
Marketing and advertising expense	205,042	207,559	365,141
Customer care and enrollment	209,234	260,902	319,103
Technology expense	43,302	46,094	48,429
General and administrative	93,069	116,530	98,183
Amortization of intangible assets	94,057	94,057	94,056
Operating lease impairment charges	2,687	25,345	1,062
Restructuring and other related charges	0	12,184	0
Goodwill and intangible asset impairment charges	10,000	0	386,553
Total operating expenses	816,352	950,341	1,551,862
Income (loss) from operations	(81,681)	(318,666)	(489,447)
Interest expense	69,472	57,069	33,505
Loss on extinguishment of debt	0	0	11,935
Other (income) expense, net	(37)	(115)	(669)
Income (loss) before income taxes	(151,116)	(375,620)	(534,218)
Income tax expense (benefit)	154	764	(24)
Net income (loss)	(151,270)	(376,384)	(534,194)
Net income (loss) attributable to noncontrolling interests	(88,013)	(227,678)	(344,837)
Net income (loss) attributable to GoHealth, Inc.	$ (63,257)	$ (148,706)	$ (189,357)
Net loss per share (Note 8):
Net income (loss) per share of Class A common stock—basic (in dollars per share)	$ (7.19)	$ (17.72)	$ (26.80)
Net income (loss) per share of Class A common stock—diluted (in dollars per share)	$ (7.19)	$ (17.72)	$ (26.80)
Weighted-average shares of Class A common stock outstanding—basic (in shares)	9,292	8,445	7,066
Weighted-average shares of Class A common stock outstanding—diluted (in shares)	9,292	8,445	7,066

GOCO Balance Sheet

2023-12-31

Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Current assets:
Cash and cash equivalents	$ 90,809	$ 16,464
Accounts receivable, net of allowance for doubtful accounts of $27 in 2023 and $89 in 2022	250	4,703
Commissions receivable - current	336,215	335,796
Prepaid expense and other current assets	49,166	57,593
Total current assets	476,440	414,556
Commissions receivable - non-current	575,482	695,637
Operating lease ROU asset	21,995	21,483
Other long-term assets	2,256	1,721
Property, equipment, and capitalized software, net	26,843	25,282
Intangible assets, net	396,554	500,611
Total assets	1,499,570	1,659,290
Current liabilities:
Accounts payable	17,705	15,148
Accrued liabilities	86,254	53,334
Commissions payable - current	118,732	122,023
Short-term operating lease liability	5,797	8,974
Deferred revenue	52,403	50,594
Current portion of long-term debt	75,000	5,270
Other current liabilities	14,122	10,112
Total current liabilities	370,013	265,455
Non-current liabilities:
Commissions payable - non-current	203,255	253,118
Long-term operating lease liability	39,547	38,367
Long-term debt, net of current portion	422,705	504,810
Other non-current liabilities	9,095	5,839
Total non-current liabilities	674,602	802,134
Commitments and Contingencies (Note 12)
Stockholders’ equity:
Preferred stock	0	0
Additional paid-in capital	654,059	626,269
Accumulated other comprehensive income (loss)	(127)	(144)
Accumulated deficit	(420,280)	(357,023)
Total stockholders’ equity attributable to GoHealth, Inc.	231,014	268,759
Non-controlling interests	174,639	273,640
Total stockholders’ equity	405,653	542,399
Total liabilities, redeemable convertible preferred stock and stockholders’ equity	1,499,570	1,659,290
Series A redeemable convertible preferred stock
Non-current liabilities:
Convertible preferred stock	49,302	49,302
Class A common stock
Stockholders’ equity:
Common stock	1	1
Treasury stock – at cost; 173 and 13 shares of Class A common stock as of December 31, 2023 and December 31, 2022, respectively.	(2,640)	(345)
Class B common stock
Stockholders’ equity:
Common stock	1	1
Series A-1 convertible preferred stock
Stockholders’ equity:
Preferred stock	$ 0	$ 0

About GoHealth Inc

GoHealth, Inc. operates as a health insurance marketplace and Medicare focused digital health company in the United States. It operates through four segments: MedicareÃ‚â€”Internal; MedicareÃ‚â€”External; Individual and Family Plans (IFP) and OtherÃ‚â€”Internal; and IFP and OtherÃ‚â€”External. The company operates a technology platform that leverages machine-learning algorithms of insurance behavioral data to optimize the process for helping individuals find the health insurance plan for their specific needs. Its products include Medicare Advantage, Medicare Supplement, Medicare prescription drug plans, and Medicare Special Needs Plans; and IFP, dental plans, vision plans, and other ancillary plans to individuals. The company sells its products through carriers and online platform, as well as independent and external agencies. GoHealth, Inc. was founded in 2001 and is headquartered in Chicago, Illinois.

CEO	Mr. Vijay Kumar Kotte
WEBSITE	gohealth.com
INDUSTRY	Insurance Property & Casualty
EMPLOYEES	2467

GoHealth Inc Frequently Asked Questions

What is the ticker symbol for GoHealth Inc? What does GOCO stand for in stocks?

GOCO is the stock ticker symbol of GoHealth Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of GoHealth Inc (GOCO)?

As of Tue May 07 2024, market cap of GoHealth Inc is 97.57 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of GOCO stock?

You can check GOCO's fair value in chart for subscribers.

What is the fair value of GOCO stock?

You can check GOCO's fair value in chart for subscribers. The fair value of GoHealth Inc is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of GoHealth Inc is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for GOCO so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is GoHealth Inc a good stock to buy?

The fair value guage provides a quick view whether GOCO is over valued or under valued. Whether GoHealth Inc is cheap or expensive depends on the assumptions which impact GoHealth Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for GOCO.

What is GoHealth Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Tue May 07 2024, GOCO's PE ratio (Price to Earnings) is -1.54 and Price to Sales (PS) ratio is 0.13. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. GOCO PE ratio will change depending on the future growth rate expectations of investors.